{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:20:50Z","timestamp":1781850050101,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency (DTRA)","doi-asserted-by":"publisher","award":["HDTRA1-13-1-0005"],"award-info":[{"award-number":["HDTRA1-13-1-0005"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.antiviral.2014.10.002","type":"journal-article","created":{"date-parts":[[2014,10,18]],"date-time":"2014-10-18T13:26:23Z","timestamp":1413638783000},"page":"26-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication"],"prefix":"10.1016","volume":"112","author":[{"given":"Cathaleen","family":"Madsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idris","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazly","family":"Shafagati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Senina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"de la Fuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa I.","family":"Hoover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda L.","family":"Fredricksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Dinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5608-4256","authenticated-orcid":false,"given":"Jonathan L.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylene","family":"Kehn-Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.10.002_b0005","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2217\/fvl.11.50","article-title":"Endemic Venezuelan equine encephalitis in the Americas: hidden under the dengue umbrella","volume":"6","author":"Aguilar","year":"2011","journal-title":"Future Virol."},{"key":"10.1016\/j.antiviral.2014.10.002_b0010","doi-asserted-by":"crossref","first-page":"e86745","DOI":"10.1371\/journal.pone.0086745","article-title":"The role of IKK\u03b2 in Venezuelan equine encephalitis virus infection","volume":"9","author":"Amaya","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2014.10.002_b0015","doi-asserted-by":"crossref","first-page":"10004","DOI":"10.1128\/JVI.01151-10","article-title":"Interplay of acute and persistent infections caused by Venezuelan equine encephalitis virus encoding mutated capsid protein","volume":"84","author":"Atasheva","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.10.002_b9000","doi-asserted-by":"crossref","first-page":"e36327","DOI":"10.1371\/journal.pone.0036327","article-title":"p53 Activation following Rift Valley fever virus infection contributes to cell death and viral production","volume":"7","author":"Austin","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2014.10.002_b0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/oxfordjournals.aje.a120178","article-title":"Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea-pig heart cells","volume":"73","author":"Berge","year":"1961","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2014.10.002_b0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbrc.2010.03.091","article-title":"Analysis of microRNAs induced by Venezuelan equine encephalitis virus infection in mouse brain","volume":"395","author":"Bhomia","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2014.10.002_b0035","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.77.6.521","article-title":"Venezuelan equine encephalomyelitis in man","volume":"77","author":"Casals","year":"1943","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2014.10.002_b0040","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nature03868","article-title":"TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing","volume":"436","author":"Chendrimada","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.10.002_b0045","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF00684844","article-title":"Comparison of the blood\u2013brain barrier and liver penetration of acridine antitumor drugs","volume":"29","author":"Cornford","year":"1992","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.10.002_b0050","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/ng1105-1163","article-title":"RNAi the natural way","volume":"37","author":"Cullen","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.antiviral.2014.10.002_b0055","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1021\/cb500476q","article-title":"The potent anti-malarial activity of acriflavine in vitro and in vivo","author":"Dana","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.antiviral.2014.10.002_b0060","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/AAC.01393-08","article-title":"Selectivity of TMC207 towards mycobacterial ATP synthase compared with that towards the eukaryotic homologue","volume":"53","author":"Haagsma","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.10.002_b9005","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1038\/emboj.2008.244","article-title":"microRNA-122 stimulates translation of hepatitis C virus RNA","volume":"27","author":"Henke","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2014.10.002_b0065","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1128\/JVI.02577-12","article-title":"Differential replication of pathogenic and nonpathogenic strains of west nile virus within astrocytes","volume":"87","author":"Hussmann","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.10.002_b0070","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1126\/science.1248465","article-title":"A viral RNA structural element alters host recognition of nonself RNA","volume":"343","author":"Hyde","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.10.002_b0075","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s004010050626","article-title":"Apoptotic cell death is an important cause of neuronal injury in experimental Venezuelan equine encephalitis virus infection of mice","volume":"93","author":"Jackson","year":"1997","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.antiviral.2014.10.002_b0080","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.10.002_b0085","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","article-title":"Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA","volume":"309","author":"Jopling","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.10.002_b0090","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1101\/sqb.2006.71.022","article-title":"Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122","volume":"71","author":"Jopling","year":"2006","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.antiviral.2014.10.002_b0095","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.antiviral.2008.01.007","article-title":"C3H\/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection","volume":"78","author":"Julander","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.10.002_b0100","doi-asserted-by":"crossref","first-page":"e34761","DOI":"10.1371\/journal.pone.0034761","article-title":"Modulation of GSK-3\u03b2 activity in Venezuelan equine encephalitis virus infection","volume":"7","author":"Kehn-Hall","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2014.10.002_b0105","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/JVI.67.3.1269-1277.1993","article-title":"Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5\u2032-noncoding region and the E2 envelope glycoprotein","volume":"67","author":"Kinney","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.10.002_b0110","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1065062","article-title":"An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans","volume":"294","author":"Lau","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.10.002_b0115","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.1065329","article-title":"An extensive class of small RNAs in Caenorhabditis elegans","volume":"294","author":"Lee","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.10.002_b0120","doi-asserted-by":"crossref","first-page":"17910","DOI":"10.1073\/pnas.0909353106","article-title":"Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization","volume":"106","author":"Lee","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.10.002_b0125","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1128\/JVI.00379-10","article-title":"Differential expression of the miR-200 family microRNAs in epithelial and B cells and regulation of epstein\u2013barr virus reactivation by the miR-200 family member miR-429","volume":"84","author":"Lin","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.10.002_b9010","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1126\/science.1102513","article-title":"Argonaute2 is the catalytic engine of mammalian RNAi","volume":"305","author":"Liu","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.10.002_b0130","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.antiviral.2013.10.004","article-title":"Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan equine encephalitis virus replication","volume":"100","author":"Lundberg","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.10.002_b0135","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0753-3322(99)80007-9","article-title":"Data of pre-clinical and early clinical trials of acriflavine and hydroxy-methyl-ellipticine reviewed, enriched by the experience of their use for 18months to 6years in combinations with other HIV1 virostatics","volume":"52","author":"Math\u00e9","year":"1998","journal-title":"Biomed. Pharmacother. [Biom\u00e9d. Pharmacoth\u00e9r.]"},{"key":"10.1016\/j.antiviral.2014.10.002_b0140","doi-asserted-by":"crossref","first-page":"33198","DOI":"10.1074\/jbc.M112.356535","article-title":"Curcumin inhibits rift valley fever virus replication in human cells","volume":"287","author":"Narayanan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.10.002_b0145","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00436-012-3163-8","article-title":"Cytotoxic effect of acriflavine against clinical isolates of Acanthamoeba spp.","volume":"112","author":"Polat","year":"2013","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.antiviral.2014.10.002_b0150","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1128\/JVI.71.9.6697-6705.1997","article-title":"Repeated emergence of epidemic\/epizootic Venezuelan equine encephalitis from a single genotype of enzootic subtype ID virus","volume":"71","author":"Powers","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.10.002_b0155","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.molcel.2007.04.016","article-title":"RNA helicase a interacts with RISC in human cells and functions in RISC loading","volume":"26","author":"Robb","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.antiviral.2014.10.002_b0160","doi-asserted-by":"crossref","first-page":"7716","DOI":"10.1093\/nar\/gkr426","article-title":"MiR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components","volume":"39","author":"Roberts","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2014.10.002_b0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2893.2009.01246.x","article-title":"HCV drug discovery aimed at viral eradication","volume":"17","author":"Schinazi","year":"2010","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2014.10.002_b0170","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0165-5728(00)00290-3","article-title":"Inflammation is a component of neurodegeneration in response to Venezuelan equine encephalitis virus infection in mice","volume":"109","author":"Schoneboom","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.antiviral.2014.10.002_b0180","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/030098589803500508","article-title":"Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H\/HeN and BALB\/c mice","volume":"35","author":"Steele","year":"1998","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.antiviral.2014.10.002_b0185","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1021\/cb200253h","article-title":"Small molecule inhibition of RISC loading","volume":"7","author":"Tan","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.antiviral.2014.10.002_b0190","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00280-012-1855-5","article-title":"9-Amino acridine pharmacokinetics, brain distribution, and in vitro\/in vivo efficacy against malignant glioma","volume":"69","author":"Teitelbaum","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.10.002_b0195","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/jcbfm.2012.193","article-title":"Hypoxia-inducible factor 1 is essential for spontaneous recovery from traumatic brain injury and is a key mediator of heat acclimation induced neuroprotection","volume":"33","author":"Umschweif","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.antiviral.2014.10.002_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/47.1.1","article-title":"Acridine\u2014a neglected antibacterial chromophore","volume":"47","author":"Wainwright","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2014.10.002_b0205","doi-asserted-by":"crossref","first-page":"24707","DOI":"10.1074\/jbc.M109.062976","article-title":"Identification of small molecules that suppress MicroRNA function and reverse tumorigenesis","volume":"285","author":"Watashi","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.10.002_b0210","doi-asserted-by":"crossref","first-page":"e30988","DOI":"10.1371\/journal.pone.0030988","article-title":"Pseudorabies virus infected porcine epithelial cell line generates a diverse set of host microRNAs and a special cluster of viral microRNAs","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2014.10.002_b0215","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.vetmic.2009.08.023","article-title":"Encephalitic alphaviruses","volume":"140","author":"Zacks","year":"2010","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2014.10.002_b0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.micpath.2011.10.001","article-title":"Changes in microRNA expression induced by rabies virus infection in mouse brains","volume":"52","author":"Zhao","year":"2012","journal-title":"Microb. Pathog."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214002824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214002824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T23:09:50Z","timestamp":1598396990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214002824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":45,"alternative-id":["S0166354214002824"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.10.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}